Scholarly Index
Bruno Paiva
Clinica Universidad de Navarra; 25,127 total citations; 521 total publications; best world rank #36
Clinica Universidad de Navarra
25,127Total citations
521Total publications
72H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 100 | ES 6 | 99.32 |
| Protein Degradation and Inhibitors | Lifetime | 101 | ES 5 | 99.07 |
| Peptidase Inhibition and Analysis | Lifetime | 256 | ES 7 | 98.89 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 843 | ES 30 | 97.98 |
| Chemokine receptors and signaling | Lifetime | 197 | ES 4 | 96.84 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 418 | ES 8 | 95.52 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 666 | ES 22 | 95.53 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 38 | ES 5 | 99.53 |
| Protein Degradation and Inhibitors | 2021-2025 | 36 | ES 4 | 99.24 |
| Peptidase Inhibition and Analysis | 2021-2025 | 167 | ES 13 | 96.20 |
| Cancer Treatment and Pharmacology | 2021-2025 | 176 | ES 14 | 96.58 |
| CAR-T cell therapy research | 2021-2025 | 816 | ES 39 | 95.34 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 339 | ES 11 | 94.11 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 848 | ES 31 | 89.75 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 261 | ES 10 | 90.63 |
| Chemokine receptors and signaling | 2021-2025 | 96 | ES 1 | 84.50 |